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ABSTRACT 
Introduction: Injeer and Ispaghula are frequently/successfully used for treatment of both primary and secondary Hyperlipidemia. 
Major cardiac diseases are directly or indirectly linked with high levels of lipids in systemic circulation.  Various medicinal herbs 
can normalize lipid profile of patients suffering from primary or secondary hyperlipidemia with or without metabolic syndrome.  
Place of research work: It was conducted at Jinnah hospital Lahore-Pakistan from January to May 2016. One hundred 
hyperlipidemic patients were enrolled for the research work. 
Type of research study: This research work was single blind placebo-controlled. 
Criteria for inclusion and exclusion: Primary or secondary hyperlipidemic patients of both gender, age range from 20 to 65 years 
were included in research. Patients suffering from any major organ disease like renal, hepatic, pulmonary diseases and already on 
drugs for major cardiac disease were excluded from the study.  
Grouping of participants: Patients were divided in four groups, 25 patients in each group. Group-I was on Injeer, Group-II was 
on Ispaghula, Group-III was on combination of these two herbal medicines, and Group-IV was considered as control group. 
Determination of TC, TG, LDL-C and HDL-C: Base line lipid profile was measured in Pathology Laboratory of JINNAH 
HOSPITAL.  
Result compilation and biostatistical analysis: After three months therapy, their lipid profile was determined and mean values 
with ±SEM were compared before and after treatment. When analyzed statistically and compared with placebo effects, all patients’ 
LDL-cholesterol was reduced significantly. HDL-cholesterol was increased in all groups of patient.  
Conclusion: Final conclusion of research work was that at specific concentration and period of ingestion of herbs like psyllium 
husk, and figs can reduce risk of hyperlipidemia leading to development of cardiac diseases, especially coronary artery disease.  
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INTRODUCTION 
Why ratio of victimization of patients by cardiac 
problems is continuously steeped up is major focus of 
medical researchers now days. Sedentary life style, use 
of fatty foods, excessive alcohol use, primary/secondary 
hyperlipidemia, and smoking are major cause of cardiac 
diseases
1
. Free radical formation is consequence of 
these habits. These free radicals form atherogenic 
plaques and cause coronary artery disease. 
Hypertension, angina, congestive cardiac failure, 
myocardial infarction and cardiac arrhythmias are end 
stage of progression of coronary artery disease
2
. 
Formation of atherosclerotic plaques leading to develop 
CAD is due to   presence of high plasma LDL-
cholesterol and lower plasma concentrations of HDL-
cholesterol
3
. Conventional method of hypolipidemic 
drug’s therapeutic philosophy is going to be unpopular 
due to unwanted pharmacological effects of these 
drugs
4
. At least in low economic human population, 
peoples are getting benefits from hypolipidemic 
medicinal herbs like Ispaghula and Injeer. Ispaghula 
seeds and husk decrease plasma cholesterol by two 
mechanisms. First ispaghula inhibit enterohepatic 
circulation of bile acids from gastrointestinal tract, 
leading to depletion of bile store in gall bladder, which 
signals hepatocytes to form bile acid instead of 
cholesterol synthesis. Second, ingested lipids are 
adsorbed with ispaghula and are excreted in stool
5-8
. 
Injeer or Ficus Carica or Figs has been used 
traditionally to treat various ailments such as 
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hyperlipidemia, diabetes mellitus, gastric problems, 
inflammation, and cancer
9
. Injeer figs are rich in 
phenolics, organic acids, and volatile compounds. 
Regarding phenolics, numbering over 4,000 distinct 
species, many of these compounds have antioxidant 
activity.  They may affect cell-to-cell signaling, receptor 
sensitivity, inflammatory enzyme activity or gene 
regulation, which play part to scavenge free radicals 
formed in many metabolic processes in human 
body
10,11,12
. Processed and dried figs are superior to 
natural figs when it comes to antioxidants
13,14,15
. 
Total and individual phenolic compounds, phenolic 
acid, chlorogenic acid, flavones, and flavonols, have 
been isolated from fresh and dried fig skins of Injeer. 
Dried Injeer contains higher amounts of phenolics than 
the pulp of fresh fruits. Phenolic acid, flavones and 
flavonols are antioxidant compounds present in fresh or 
in some dried fruits, vegetables, even in aesthetic plants. 
Medical researchers are keenly interested to do work on 
these herbs, so that they can recommend herbal 
medication to clinicians to get good drug and patient 
compliance
16,17,18
.  
MATERIAL & METHOD 
Jinnah hospital Lahore was place of this single blind 
placebo-based study conducted from January to May 
2016. One hundred primary and secondary 
hyperlipidemic patients were selected for study. 
Patient’s age range was from 20 to 65 years. Inclusion 
criteria were primary, secondary hyperlipidemic 
patients, without medical history of victimization of 
patient by any major cardiac disease like Angina, 
Congestive Cardiac Failure, Myocardial Infarction, and 
Cardiac Arrhythmias. Exclusion Criteria were any 
thyroid, renal, hepatic disease, alcohol users, chain 
smokers, and taking any medicine on regular basis. 
Written and explained consent was taken from all 
participants and approved by research ethics committee 
of the hospital. Patients were divided in four equal 
groups, comprising 25 patients in each group. Their 
baseline determination of lipid profile was made at 
Biochemistry laboratory of the hospital. Group-I was 
advised to take Injeer 10 grams daily in three equally 
divided doses. Group-II was advised to take 10 grams 
of Ispaghula daily in three divided doses before each 
meal for three months. Group-III was advised to take 10 
grams Injeer and 10 grams Ispaghula in three divided 
doses daily for three months. Group-IV was advised to 
take one capsule (containing grinded wheat) with each 
meal time, thrice daily for the period of three months. 
They were advised to come for follow up monthly. 
Their lipid profile was measured monthly. After three 
months their lipid profile was measured. Results were 
compiled and statistically analyzed by using SPSS 
version 8.1.0.0 2012. Mean values of the tested 
parameters were expressed with ± SEM and paired ‘t’ 
test was applied to determine significant changes in 
mean values before after treatment. P-value >0.05 was 
considered as non-significant change, p-value <0.01 
was considered as significant and p-value <0.001 was 
considered as highly significant change in results.  
RESULTS 
Injeer decreased TG 33.2 mg/dl, TC 25.9 mg/dl, LDL-c 
20.1 mg/dl and increased HDL cholesterol 7.7 mg/dl in 
24 patients. Ispaghula decreased TG 33.2, TC 22.6, 
LDL cholesterol 17.8 mg/dl and increased HDL 
cholesterol 5.3 mg/dl in 24 hyperlipidemic patients. 
Injeer and Ispaghula when given in 22 hyperlipidemic 
patients, these herbs reduced LDL-cholesterol 25.7 
mg/dl and increased HDL-cholesterol 8.7 mg/dl. Other 
biostatistically analyzed results are shown in following 
table. 
 
Table 1: Effects of Injeer, Ispaghula and combination of these two herbs on Triglycerides, Total-cholesterol, LDL 
and HDL-cholesterol in three months therapy 
Herbs used Lipid 
type  
At start of 
study 
At end of 
study 
Difference before 
and after treatment 
% change p-value 
Injeer (n=24) TG 
TC 
LDL-c 
HDL-c 
199.11±1.88 
302.33±1.11 
236.17±1.87   
40.05±2.19  
165.91±1.99 
276.39±2.77 
216.08±1.66 
47.74±1.45 
33.2 
25.9 
20.1 
7.7 
16.7 
8.6 
8.5 
16.1 
<0.001 
<0.01 
<0.01 
<0.001 
Ispaghula 
(n= 24) 
TG 
TC 
LDL-c 
HDL-c 
211.01±1.20 
276.76±2.88 
228.76±2.91 
33.33±1.61 
177.78±1.12 
254.15±2.28 
210.92±2.86 
38.60±2.10 
33.2 
22.6 
17.8 
5.3 
15.7 
8.2 
7.8 
13.7 
<0.001 
<0.01 
>0.01 
<0.001 
Combined 
herbs (n=22) 
TG 
TC 
LDL-c 
HDL-c 
220.00±2.11 
333.18±1.99 
234.65±3.76 
38.87±1.42 
190.08±2.16 
312.11±3.87 
208.97±1.32 
47.54±2.86 
29.9 
21.1 
25.7 
8.7 
13.6 
6.3 
11.0 
18.3 
<0.001 
<0.01 
<0.001 
<0.001 
Control 
Group 
(n=25) 
TG 
TC 
LDL-c 
HDL-c 
154.11±1.92 
222.15±3.31 
221.97±2.10  
35.43±2.50 
151.66±1.34 
220.16±2.22 
220.12±2.00 
36.19±3.76 
2.5 
2.0 
1.9 
0.8 
1.6 
0.9 
0.9 
2.2 
>0.05 
>0.05 
>0.05 
>0.05 
KEY:    All parameters and change in these parameters before and after treatment are measured in mg/dl, and their mean values 
are written with ±SEM. P-value <0.001= highly significant, P-value <0.01= significant, p-value >0.05 = non-significant changes 
in lipid profile parameters tested.  n stands for  sample size. TG stands for triglycerides, TC stands for total cholesterol, LDL-c 
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stands for low density lipoprotein cholesterol, HDL-c stands for high density lipoprotein cholesterol. Combined herbs mean 
combination of Injeer and Ispaghula. 
DISCUSSION 
Many cardiac diseases are responsible for human 
morbidity and mortality all over the world. Allopathic 
drugs used in cardiac diseases, due to their toxic 
effects, have had proved laymen proverb ‘cure is worst 
than illness’. So researchers are seriously taking 
interest in research work on medicinal herbs due to 
their lesser side effects.  Ispaghula is well known, since 
long for its hypolipidemic and normalizing 
gastrointestinal motility. Fruit Injeer (Figs) are one of 
the earliest fruits grown by human beings in history. 
Though figs (Injeer) are not available throughout the 
year. Figs are used for digestion of foods, for treating 
hypertension, diabetes mellitus, anemia, obesity, bones 
deformity, and for prevention of complications leading 
to cause heart diseases like oxidative stress and 
Hyperlipidemia. Injeer or Ficus Carica or Figs contain 
flavonoids, various phytochemicals, wide variety of 
organic acids, furanocoumarins, polysaccharides. All 
these compounds have one way or other antioxidant 
effect. In our research Figs consumption by 25 
hyperlipidemic patients for three months decreased 
LDL-cholesterol 20.1 mg/dl, and increased HDL-
cholesterol 7.7 mg/dl. D. Pal et al
19
 proved near to 
same results as ours. They mentioned mechanism of 
antioxidant activity of this herb that active ingredients 
present in injeer scavenge and use free radicals and 
prevent cell damage in body. E. R. Stadtman
20
 used 
combination of ispaghula husk and Figs and proved 
30.1 mg/dl reduction in LDL-cholesterol. These results 
match with ours as in our observation; combination of 
two herbs reduced LDL-cholesterol 25.7 mg/dl and 
increased HDL-cholesterol 8.7 mg/dl in three months 
therapy by two herbs. E. A. Lissi et al
21
 used Injeer or 
Figs in 78 hyperlipidemic patients and proved that this 
herbal medicine reduced plasma total cholesterol 34.88 
mg/dl, LDL-cholesterol 9.96 mg/dl and increased 
HDL-cholesterol 2.04 mg/dl. These results are in 
contrast with our results. Reason to contrast in these 
two studies are due to selective patients in these 
researchers study as they only selected secondary 
hyperlipidemic patients and used 5 grams Figs for one 
week only. We proved LDL-cholesterol reduction 17.8 
mg/dl when ispaghula husk was used by 25 patients for 
the period of 3 months. HDL-cholesterol increased 5.7 
mg/dl in our patients. These results match with results 
of study conducted by Hossain P et al
22 
who proved 
20.04 mg/dl reduction in LDL-cholesterol when they 
advised their patients to take ispaghula for 8 weeks. 
Verma SK et al
23
 used combination of Injeer or figs 
with ispaghula seeds in 12 patients and proved LDL-
cholesterol reduction only 8.07 mg/dl, while in our 
patients this decrease was 25.7 mg/dl. Obvious 
contrasts in results are due to sample size. Drewnowski 
A et al
24
 have proved in their study that ispaghula husk 
is better than seeds for interrupting enterohepatic 
circulation leading to synthesis of bile by hepatic cells 
instead of cholesterol.  
CONCLUSION: 
It was concluded from this work that lipid profile of 
hyperlipidemic patients can be normalized by taking 
specific herbs having antihyperlipidemic characteristics 
like psyllium husk and Injeer.  
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